Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregor Weirich

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
European Urology|May 11, 2015
Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancerTobias Maurer, Gregor Weirich, Margret Schottelius, et al.
European Urology|December 27, 2011
Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomyTobias Maurer, Michael Souvatzoglou, Hubert Kübler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2018
Molecular Lymph Node Status for Prognostic Stratification of Prostate Cancer Patients Undergoing Radical Prostatectomy with Extended Pelvic Lymph Node DissectionMatthias M Heck, Margitta Retz, Miriam Bandur, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2014
11C-Choline PET/pathology image coregistration in primary localized prostate cancerAnca-Ligia Grosu, Gregor Weirich, Christina Wendl, et al.
European Urology|March 8, 2013
Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping studyMatthias M Heck, Margitta Retz, Miriam Bandur, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 8, 2013
Tumour volume delineation in prostate cancer assessed by [11C]choline PET/CT: validation with surgical specimensRalph A Bundschuh, Christina M Wendl, Gregor Weirich, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 1, 2010
[11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft modelBernd J Krause, Michael Souvatzoglou, Ken Herrmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2011
The sensitivity of [11C]choline PET/CT to localize prostate cancer depends on the tumor configurationMichael Souvatzoglou, Gregor Weirich, Sarah Schwarzenboeck, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2005
Investigation of genetic variants of genes of the hemochromatosis pathway and their role in breast cancerBenny K Abraham, Christina Justenhoven, Beate Pesch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2008
Imaging bone and soft tissue tumors with the proliferation marker [18F]fluorodeoxythymidineAndreas K Buck, Ken Herrmann, Christian Meyer Zum Büschenfelde, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
European Urology|May 11, 2015
Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancerTobias Maurer, Gregor Weirich, Margret Schottelius, et al.
European Urology|December 27, 2011
Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomyTobias Maurer, Michael Souvatzoglou, Hubert Kübler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2018
Molecular Lymph Node Status for Prognostic Stratification of Prostate Cancer Patients Undergoing Radical Prostatectomy with Extended Pelvic Lymph Node DissectionMatthias M Heck, Margitta Retz, Miriam Bandur, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2014
11C-Choline PET/pathology image coregistration in primary localized prostate cancerAnca-Ligia Grosu, Gregor Weirich, Christina Wendl, et al.
European Urology|March 8, 2013
Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping studyMatthias M Heck, Margitta Retz, Miriam Bandur, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 8, 2013
Tumour volume delineation in prostate cancer assessed by [11C]choline PET/CT: validation with surgical specimensRalph A Bundschuh, Christina M Wendl, Gregor Weirich, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 1, 2010
[11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft modelBernd J Krause, Michael Souvatzoglou, Ken Herrmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2011
The sensitivity of [11C]choline PET/CT to localize prostate cancer depends on the tumor configurationMichael Souvatzoglou, Gregor Weirich, Sarah Schwarzenboeck, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2005
Investigation of genetic variants of genes of the hemochromatosis pathway and their role in breast cancerBenny K Abraham, Christina Justenhoven, Beate Pesch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2008
Imaging bone and soft tissue tumors with the proliferation marker [18F]fluorodeoxythymidineAndreas K Buck, Ken Herrmann, Christian Meyer Zum Büschenfelde, et al.
Pageof 8